Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsectors
Other
Small molecules
Indications
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Diseases of the eye / ophthalmology
Respiratory / pulmonology
Digestive system / gastroenterology
Genitourinary system / Urology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Products
In development: 6
On the market: 4
Description
Calliditas Therapeutics AB is a Swedish specialty biopharmaceutical company focused on developing and commercializing therapies for rare diseases with significant unmet medical needs, particularly in renal and hepatic disorders. The company combines pharmaceutical development expertise with strategic partnerships to advance and market novel treatments, including approved therapies for IgA nephropathy and a pipeline of investigational medicines.
